LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,423,018 | -14.5% | 57,127 | +2.9% | 0.00% | 0.0% |
Q2 2023 | $4,001,477 | +102449.4% | 55,499 | +4.6% | 0.00% | -20.0% |
Q1 2023 | $3,902 | +15.2% | 53,041 | +4.6% | 0.01% | 0.0% |
Q4 2022 | $3,387 | -99.9% | 50,699 | +4.5% | 0.01% | -16.7% |
Q3 2022 | $4,177,000 | -2.2% | 48,507 | +1.4% | 0.01% | 0.0% |
Q2 2022 | $4,269,000 | -17.6% | 47,844 | +3.9% | 0.01% | -14.3% |
Q1 2022 | $5,178,000 | -25.5% | 46,027 | +2.3% | 0.01% | -22.2% |
Q4 2021 | $6,951,000 | +8.0% | 45,003 | -2.6% | 0.01% | 0.0% |
Q3 2021 | $6,438,000 | -3.1% | 46,211 | -8.7% | 0.01% | 0.0% |
Q2 2021 | $6,641,000 | -4.3% | 50,622 | +11.2% | 0.01% | 0.0% |
Q1 2021 | $6,939,000 | +52.3% | 45,515 | -0.6% | 0.01% | +50.0% |
Q4 2020 | $4,555,000 | +4.4% | 45,806 | +0.0% | 0.01% | -14.3% |
Q3 2020 | $4,365,000 | -28.6% | 45,790 | -16.3% | 0.01% | -30.0% |
Q2 2020 | $6,117,000 | +34.8% | 54,688 | -12.3% | 0.01% | 0.0% |
Q1 2020 | $4,537,000 | -30.6% | 62,384 | -0.5% | 0.01% | -9.1% |
Q4 2019 | $6,542,000 | -0.1% | 62,725 | -4.6% | 0.01% | -8.3% |
Q3 2019 | $6,548,000 | -13.6% | 65,781 | -0.9% | 0.01% | -14.3% |
Q2 2019 | $7,579,000 | -10.3% | 66,393 | -1.2% | 0.01% | -12.5% |
Q1 2019 | $8,449,000 | -7.9% | 67,209 | -0.6% | 0.02% | -20.0% |
Q4 2018 | $9,172,000 | -35.3% | 67,591 | +30.8% | 0.02% | -25.9% |
Q3 2018 | $14,185,000 | +27.9% | 51,676 | -3.5% | 0.03% | +22.7% |
Q2 2018 | $11,094,000 | +30.9% | 53,548 | +4.3% | 0.02% | +22.2% |
Q1 2018 | $8,478,000 | +22.1% | 51,333 | +1.2% | 0.02% | +28.6% |
Q4 2017 | $6,944,000 | +17.2% | 50,710 | +16.5% | 0.01% | +7.7% |
Q3 2017 | $5,925,000 | +20.3% | 43,518 | +7.3% | 0.01% | +18.2% |
Q2 2017 | $4,924,000 | +16.4% | 40,559 | +1.5% | 0.01% | +10.0% |
Q1 2017 | $4,231,000 | +41.2% | 39,979 | +35.6% | 0.01% | +25.0% |
Q4 2016 | $2,996,000 | +6.1% | 29,489 | +6.6% | 0.01% | 0.0% |
Q3 2016 | $2,823,000 | -8.7% | 27,660 | +6.7% | 0.01% | -11.1% |
Q2 2016 | $3,093,000 | +17.7% | 25,932 | +5.7% | 0.01% | +12.5% |
Q1 2016 | $2,627,000 | +0.7% | 24,527 | +2.0% | 0.01% | 0.0% |
Q4 2015 | $2,608,000 | +43.5% | 24,057 | +13.4% | 0.01% | +33.3% |
Q3 2015 | $1,817,000 | -12.8% | 21,211 | +2.7% | 0.01% | -14.3% |
Q2 2015 | $2,084,000 | +14.5% | 20,650 | -12.5% | 0.01% | +40.0% |
Q1 2015 | $1,820,000 | +60.9% | 23,598 | +11.0% | 0.01% | +66.7% |
Q4 2014 | $1,131,000 | +9.5% | 21,253 | -3.3% | 0.00% | 0.0% |
Q3 2014 | $1,033,000 | -28.9% | 21,978 | -5.8% | 0.00% | -25.0% |
Q2 2014 | $1,453,000 | +0.3% | 23,328 | +8.3% | 0.00% | 0.0% |
Q1 2014 | $1,449,000 | +23.3% | 21,544 | -3.5% | 0.00% | +33.3% |
Q4 2013 | $1,175,000 | +51.8% | 22,335 | +24.8% | 0.00% | +50.0% |
Q3 2013 | $774,000 | +14.8% | 17,895 | -0.7% | 0.00% | 0.0% |
Q2 2013 | $674,000 | – | 18,017 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |